While PSD3, CD274, and TNFSF18 were found to be up-regulated in ESCC and associated with immune-related features, only PSD3 demonstrated a significant and paradoxical correlation with patient survival—higher expression predicting better prognosis. Here, CD274 is linked to esophageal squamous cell carcinoma.